¸£Àû¼§

Home
Photo of Peter Gennemark

Peter Gennemark

Adjunct Associate Professor, Docent

My research aims to improve understanding of diabetes and cardiovascular disease and their treatment, by mathematical modelling.

Systems pharmacology – a pharma industry collaboration

Peter Gennemark (Principal scientist at AstraZeneca, Gothenburg, Sweden) is adjunct senior lecturer at IMT. Peter has an established collaboration in systems pharmacology with Gunnar Cedersund (IMT). His research is directed towards systems pharmacology in the diabetes and cardiovascular disease areas, with the aim of increasing knowledge of biology, disease progression and drug intervention in these areas.

Publications

2025

Quentin Vicentini, Dennis Hekman, Deepak Bhatt, Rouven Stulz, Mahya Dezfouli, Peter Gennemark, Nicola Guzzi, Naoko Toki, Bojana Lazovic, Carolina Tangemo, Shalini Andersson, Samir EL Andaloussi, Anders Dahlen (2025) Bioconjugate chemistry (Article in journal)

2024

Erica Bäckström, Alessandro Bonetti, Per Johnsson, Stefan Öhlin, Anders Dahlén, Patrik Andersson, Shalini Andersson, Peter Gennemark (2024) Molecular Therapy - Nucleic Acids, Vol. 35, p. 102133-102133, Article 102133 (Article in journal)
Hamidreza Arjmandi, Kajsa P. Kanebratt, Liisa Vilen, Peter Gennemark, Adam Noel (2024) PLOS ONE, Vol. 19, Article e0310109 (Article in journal)
Sophie Rigal, Belén Casas, Kajsa P. Kanebratt, Charlotte Wennberg Huldt, Lisa U. Magnusson, Erik Mullers, Fredrik Karlsson, Maryam Clausen, Sara F. Hansson, Louise Leonard, Jonathan Cairns, Rasmus Jansson Lofmark, Carina Ammala, Uwe Marx, Peter Gennemark, Gunnar Cedersund, Tommy B. Andersson, Liisa K. Vilen (2024) Communications Biology, Vol. 7, Article 877 (Article in journal)
Christian Simonsson, Elin Nyman, Peter Gennemark, Peter Gustafsson, Ingrid Hotz, Mattias Ekstedt, Peter Lundberg, Gunnar Cedersund (2024) Clinical Nutrition, Vol. 43, p. 1532-1543 (Article in journal)

Research

Illustration of a person holding arms out, and a mirrored version showing internal organs.

Systems Biology

By combining mathematical models, prior knowledge, and experimental data, we unravel biological mechanisms and contribute to the development of new drugs and clinical tools.

Research projects

An illustration with red tones. You see a human in the middle with a screen on both sides.

Knowledge Driven Drug Development

In this project, financed by VR medicine’s investment in pharmacy, the researchers are working with AstraZeneca to develop a new type of knowledge driven drug development.

Organisation

Computer simulation of a person

Department of Biomedical Engineering (IMT)

A national centre for research, PhD studies and graduate studies within biomedical engineering, since 1972.
A monitor displaying health data for a patient.

Division of Biomedical Engineering (MT)

A national centre for research, education and innovation within the field of biomedical engineering.

Tags